JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB213480

Anti-PD-L1 antibody [EPR20529]

5

(5 Reviews)

|

(71 Publications)

Anti-PD-L1 antibody [EPR20529] (ab213480) is a rabbit monoclonal antibody detecting PD-L1 in Western Blot, IP, ICC/IF. Suitable for Mouse.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
- Over 70 publications

View Alternative Names

CD274, B7h1, Pdcd1l1, Pdcd1lg1, Pdl1, Cd274, Programmed cell death 1 ligand 1, PD-L1, PDCD1 ligand 1, Programmed death ligand 1, B7 homolog 1, B7-H1

5 Images
Immunocytochemistry/ Immunofluorescence - Anti-PD-L1 antibody [EPR20529] (AB213480)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-PD-L1 antibody [EPR20529] (AB213480)

ab213480 staining PD-L1 in RAW264.7 from Mouse macrophage cell line transformed with Abelson murine leukemia virus by ICC/IF (Immunocytochemistry/immunofluorescence). Cells were fixed with 100% Methanol. Samples were incubated with ab213480 at 0.4 μg/ml. AlexaFluor®488 Goat anti-Rabbit (ab150077) was used as the secondary antibody at 2 μg/ml. Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594)(ab196889) was used as counterstain at 2.5 μg/ml. DAPI used as nuclear counterstain. Confocal image showing membranous staining on RAW 264.7 cells treated with IFN-γ (100 ng/ml) for 24 hours.

Immunoprecipitation - Anti-PD-L1 antibody [EPR20529] (AB213480)
  • IP

Supplier Data

Immunoprecipitation - Anti-PD-L1 antibody [EPR20529] (AB213480)

PD-L1 was immunoprecipitated from 0.35 mg of Mouse placenta lysate with ab213480 at 1/30 dilution.

Western blot was performed from the immunoprecipitate using ab213480 at 1/500 dilution.

VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/1,000 dilution.

Lane 1 : Mouse placenta lysate, 10 μg (Input).

Lane 2 : ab213480 IP in mouse placenta lysate.

Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab213480 in mouse placenta lysate.

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 3 seconds.

All lanes:

Immunoprecipitation - Anti-PD-L1 antibody [EPR20529] (ab213480)

Predicted band size: 33 kDa

Observed band size: 55-60 kDa

false

Western blot - Anti-PD-L1 antibody [EPR20529] (AB213480)
  • WB

Lab

Western blot - Anti-PD-L1 antibody [EPR20529] (AB213480)

This WB was performed by using YCA-R20529(BF)-111A H3L2 YR120921PJ, 1 : 5000 dilution. Working concentration : 0.402 μg/ml.

Blocking buffer and concentration : 5% NFDM/TBST

Diluting buffer and concentration : 5% NFDM/TBST

All lanes:

Western blot - Anti-PD-L1 antibody [EPR20529] (ab213480) at 1/5000 dilution

Lane 1:

Untreated RAW264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate at 20 µg

Lane 2:

RAW264.7 treated with 100 ng/ml IFN gamma for 48 h, whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 33 kDa

Observed band size: 40-60 kDa

false

Exposure time: 37s

Western blot - Anti-PD-L1 antibody [EPR20529] (AB213480)
  • WB

Supplier Data

Western blot - Anti-PD-L1 antibody [EPR20529] (AB213480)

Blocking/Dilution buffer : 5% NFDM/TBST.

The molecular weight observed is consistent with what has been described in the literature. PMID : 15353579.

All lanes:

Western blot - Anti-PD-L1 antibody [EPR20529] (ab213480) at 1/1000 dilution

All lanes:

Mouse placenta lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 33 kDa

Observed band size: 40-60 kDa

false

Exposure time: 15s

Western blot - Anti-PD-L1 antibody [EPR20529] (AB213480)
  • WB

AbReview78135****

Western blot - Anti-PD-L1 antibody [EPR20529] (AB213480)

The mAb is specific for mouse mPDL1 and does not recognise hPDL1. As expected a specific 48kDa band is observed in RAW264.7 and MEFS cell extract after Interferon-gamma treatment. No bands are observed in RAW264.7 and MEFS WT and in MEFS KO with and without Interferon-gamma treatment.

All lanes:

Western blot - Anti-PD-L1 antibody [EPR20529] (ab213480) at 100 µg

Lane 1:

HEK mPDL1 cell lysate at 20 µg

Lane 2:

HEK hPDL1 cell lysate at 20 µg

Lane 3:

HEK CL7 at 20 µg

Lane 4:

RAW 264.7 Wild-type (Mouse macrophage cell line transformed with Abelson murine leukemia virus) whole cell lysate at 100 µg

Lane 5:

RAW 264.7 (Mouse macrophage cell line transformed with Abelson murine leukemia virus) whole cell lysate treated with Interferon-gamma at 100 µg

Lane 6:

MEF Wild-type (Mouse embryonic fibroblast cell line) whole cell lysate at 100 µg

Lane 7:

MEF (Mouse embryonic fibroblast cell line) whole cell lysate treated with Interferon-gamma at 100 µg

Lane 8:

MEF mPDL1 KO cell lysate at 100 µg

Lane 9:

MEF mPDL1 KO treated with Interferon-gamma at 100 µg

Predicted band size: 33 kDa

Observed band size: 48 kDa

false

Exposure time: 5min

This image is courtesy of an anonymous collaborator.

  • Carrier free

    Anti-PD-L1 antibody [EPR20529] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR20529

Isotype

IgG

Carrier free

No

Reacts with

Mouse

Applications

ICC/IF, WB, IP

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

This antibody is not suitable in IHC-FR for mouse samples

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCFr" : {"fullname" : "Immunohistochemistry (Frozen sections)", "shortname":"IHC-Fr"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Mouse": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCFr-species-checked": "notRecommended", "IHCFr-species-dilution-info": "", "IHCFr-species-notes": "<p></p>" } } }

You may be interested in:

AB277712

Human PD-L1 ELISA Kit [28-8]

0

0 Reviews

View product

We recommend this product because it’s often used in the same experiment or related research.

We advise that you always check the datasheet to ensure it fits your experiments, or contact ourtechnical teamfor help.

Product details

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

PD-L1 also known as Programmed Death-Ligand 1 or CD274 is a protein involved in immune modulation. Mechanically PD-L1 interacts with its receptors particularly PD-1 to regulate cellular immune responses. This transmembrane protein has a calculated molecular weight of approximately 33 kDa. PD-L1 is expressed on various cell types including tumor cells and immune cells such as dendritic cells macrophages and B cells. Its expression is often upregulated in response to inflammatory cytokines.
Biological function summary

PD-L1 plays a central role in immune evasion mechanisms utilized by tumors. It is not part of a larger protein complex but directly interacts with PD-1 and CD80. When PD-L1 binds to PD-1 it sends inhibitory signals leading to decreased T cell activation and proliferation allowing cancer cells to avoid immune destruction. PD-L1 expression provides a mechanism for tumors to suppress immune surveillance facilitating tumor progression.

Pathways

PD-L1 is integral to the immune checkpoint pathway which is an important regulator of immune response. The interaction between PD-L1 and PD-1 provides a mechanism for immune tolerance which is part of the broader adaptive immune system pathway. PD-L1 is related to other immune checkpoint proteins such as CTLA-4 in its function to limit autoreactivity and promote immune homeostasis.

PD-L1 is most associated with cancer particularly in tumors such as melanoma and non-small cell lung cancer. PD-L1 expression on tumor cells often correlates with poor prognosis. PD-L1 directly interacts with PD-1 in these cancers a target for immunotherapies such as checkpoint inhibitors which aim to block this interaction and restore immune activity against tumors. PD-L1 involvement extends to autoimmune disorders where altered expression can impact tolerance and lead to immune-related tissue damage.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Plays a critical role in induction and maintenance of immune tolerance to self (PubMed : 11238124). As a ligand for the inhibitory receptor PDCD1/PD-1, modulates the activation threshold of T-cells and limits T-cell effector response (PubMed : 11238124). Through a yet unknown activating receptor, may costimulate T-cell subsets that predominantly produce interleukin-10 (IL10) (PubMed : 11015443, PubMed : 12719480).. The PDCD1-mediated inhibitory pathway is exploited by tumors to attenuate anti-tumor immunity and escape destruction by the immune system, thereby facilitating tumor survival (PubMed : 12218188, PubMed : 27281199). The interaction with PDCD1/PD-1 inhibits cytotoxic T lymphocytes (CTLs) effector function (PubMed : 12218188). The blockage of the PDCD1-mediated pathway results in the reversal of the exhausted T-cell phenotype and the normalization of the anti-tumor response, providing a rationale for cancer immunotherapy (PubMed : 12218188).
See full target information Cd274

Publications (71)

Recent publications for all applications. Explore the full list and refine your search

Journal of translational medicine 21:898 PubMed38082290

2023

The preprogrammed anti-inflammatory phenotypes of CD11c macrophages by Streptococcus pneumoniae aminopeptidase N safeguard from allergic asthma.

Applications

Unspecified application

Species

Unspecified reactive species

Shifei Yao,Danlin Weng,Yan Wang,Yanyu Zhang,Qi Huang,Kaifeng Wu,Honghui Li,Xuemei Zhang,Yibing Yin,Wenchun Xu

Journal for immunotherapy of cancer 11: PubMed38056894

2023

Caspase-9 inhibition triggers Hsp90-based chemotherapy-mediated tumor intrinsic innate sensing and enhances antitumor immunity.

Applications

Unspecified application

Species

Unspecified reactive species

Jingyang Li,Xiaoyu Han,Mayu Sun,Weida Li,Guanghuan Yang,Huiyi Chen,Bao Guo,Jingquan Li,Xiaoguang Li,Hui Wang

Science advances 9:eadi2465 PubMed38055816

2023

Inhibition of ACLY overcomes cancer immunotherapy resistance via polyunsaturated fatty acids peroxidation and cGAS-STING activation.

Applications

Unspecified application

Species

Unspecified reactive species

Wei Xiang,Hongwei Lv,Fuxue Xing,Xiaoyan Sun,Yue Ma,Lu Wu,Guishuai Lv,Qianni Zong,Liang Wang,Zixin Wu,Qiyu Feng,Wen Yang,Hongyang Wang

The Journal of clinical investigation 133: PubMed38038129

2023

CRISPR screening identifies the deubiquitylase ATXN3 as a PD-L1-positive regulator for tumor immune evasion.

Applications

Unspecified application

Species

Unspecified reactive species

Shengnan Wang,Radhika Iyer,Xiaohua Han,Juncheng Wei,Na Li,Yang Cheng,Yuanzhang Zhou,Qiong Gao,Lingqiang Zhang,Ming Yan,Zhaolin Sun,Deyu Fang

Journal of nanobiotechnology 21:382 PubMed37858171

2023

Tumor microenvironment-responsive DNA-based nanomedicine triggers innate sensing for enhanced immunotherapy.

Applications

Unspecified application

Species

Unspecified reactive species

Jinyang Li,Xiaoyu Han,Shanshan Gao,Yumeng Yan,Xiaoguang Li,Hui Wang

Journal of Cancer 14:3295-3308 PubMed37928424

2023

Ablation of the GDP-fucose transporter suppresses lung cancer cell proliferation and migration by reducing expression of PD-L1.

Applications

Unspecified application

Species

Unspecified reactive species

Yingshu Zhang,Nianzhu Zhang,Wanli Song,Sabiha Yousuf,Wenzhe Li

ACS omega 8:36435-36448 PubMed37810687

2023

Design of siRNA Bioconjugates for Efficient Control of Cancer-Associated Membrane Receptors.

Applications

Unspecified application

Species

Unspecified reactive species

Jong Won Lee,Jiwoong Choi,Eun Hye Kim,Jiwon Choi,Sun Hwa Kim,Yoosoo Yang

Nature communications 14:5740 PubMed37714844

2023

Activation of melanocortin-1 receptor signaling in melanoma cells impairs T cell infiltration to dampen antitumor immunity.

Applications

Unspecified application

Species

Unspecified reactive species

Yazhong Cui,Yang Miao,Longzhi Cao,Lifang Guo,Yue Cui,Chuanzhe Yan,Zhi Zeng,Mo Xu,Ting Han

Theranostics 13:4574-4600 PubMed37649598

2023

Histone deacetylase-mediated tumor microenvironment characteristics and synergistic immunotherapy in gastric cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Yilin Lin,Xiangxiang Jing,Zhihua Chen,Xiaoxian Pan,Duo Xu,Xiang Yu,Fengyun Zhong,Long Zhao,Changjiang Yang,Bo Wang,Shan Wang,Yingjiang Ye,Zhanlong Shen

Molecular carcinogenesis 62:1369-1377 PubMed37249360

2023

Potentiated effects of lactate receptor GPR81 on immune microenvironment in breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Shenchao Guo,Jianliang Zhou,Pengrong Lou,Lijuan Weng,Xiaoxian Ye,Jianxin Guo,Huan Liu,Ruishuang Ma
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Associated Products

Select an associated product type
Alternative Product
Primary Antibodies

AB210189

PE Anti-PD-L1 antibody [10F.9G2]

primary-antibodies

pe-pd-l1-antibody-10f9g2-ab210189

0

(0 reviews)

Alternative Product
Primary Antibodies

AB259283

Anti-PD-L1 antibody [29E.2A3]

primary-antibodies

pd-l1-antibody-29e2a3-ab259283

0

(0 reviews)

Alternative Product
Primary Antibodies

AB228463

Anti-PD-L1 antibody [SP142] - C-terminal, prediluted

primary-antibodies

pd-l1-antibody-sp142-c-terminal-prediluted-ab228463

0

(0 reviews)

Alternative Product
Primary Antibodies

AB213359

Alexa Fluor® 568 Anti-PD-L1 antibody [28-8]

primary-antibodies

alexa-fluor-568-pd-l1-antibody-28-8-ab213359

0

(0 reviews)

Alternative Product
Primary Antibodies

AB237402

Alexa Fluor® 488 Anti-PD-L1 antibody [73-10]

primary-antibodies

alexa-fluor-488-pd-l1-antibody-73-10-ab237402

0

(0 reviews)

Alternative Product
Primary Antibodies

AB209960

Alexa Fluor® 647 Anti-PD-L1 antibody [28-8] - Extracellular domain

primary-antibodies

alexa-fluor-647-pd-l1-antibody-28-8-extracellular-domain-ab209960

0

(0 reviews)

Alternative Product
Primary Antibodies

AB215251

Alexa Fluor® 647 Anti-PD-L1 antibody [EPR19759]

primary-antibodies

alexa-fluor-647-pd-l1-antibody-epr19759-ab215251

0

(0 reviews)

Alternative Product
Primary Antibodies

AB267563

Alexa Fluor® 647 Anti-PD-L1 antibody [SP142]

primary-antibodies

alexa-fluor-647-pd-l1-antibody-sp142-ab267563

4

(2 reviews)

Alternative Product
Primary Antibodies

AB216742

Alexa Fluor® 594 Anti-PD-L1 antibody [EPR19759]

primary-antibodies

alexa-fluor-594-pd-l1-antibody-epr19759-ab216742

0

(0 reviews)

Alternative Product
Primary Antibodies

AB206967

APC Anti-PD-L1 antibody [28-8]

primary-antibodies

apc-pd-l1-antibody-28-8-ab206967

0

(0 reviews)

Alternative Product
Primary Antibodies

AB220314

Alexa Fluor® 568 Anti-PD-L1 antibody [EPR19759]

primary-antibodies

alexa-fluor-568-pd-l1-antibody-epr19759-ab220314

0

(0 reviews)

Alternative Product
Primary Antibodies

AB209959

Alexa Fluor® 488 Anti-PD-L1 antibody [28-8]

primary-antibodies

alexa-fluor-488-pd-l1-antibody-28-8-ab209959

5

(1 reviews)

Alternative Product
Primary Antibodies

AB209962

PE Anti-PD-L1 antibody [28-8]

primary-antibodies

pe-pd-l1-antibody-28-8-ab209962

0

(0 reviews)

Alternative Product
Primary Antibodies

AB224027

FITC Anti-PD-L1 antibody [28-8]

primary-antibodies

fitc-pd-l1-antibody-28-8-ab224027

0

(0 reviews)

Alternative Product
Primary Antibodies

AB209961

HRP Anti-PD-L1 antibody [28-8]

primary-antibodies

hrp-pd-l1-antibody-28-8-ab209961

0

(0 reviews)

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com